59 related articles for article (PubMed ID: 6194090)
1. [Use of chromogenic substrate in cerebrospinal fluid diagnosis].
Cullmann W; Dick W; Müller N
Fortschr Neurol Psychiatr; 1983 Jul; 51(7):255-8. PubMed ID: 6194090
[TBL] [Abstract][Full Text] [Related]
2. An amidolytic assay for determination of alpha 1-antitrypsin in serum and in cerebrospinal fluid.
Dick W; Cullmann W
J Clin Chem Clin Biochem; 1982 Feb; 20(2):57-60. PubMed ID: 6175723
[TBL] [Abstract][Full Text] [Related]
3. A chromogenic assay for evaluation of alpha 2-macroglobulin level in serum and cerebrospinal fluid.
Cullmann W; Dick W
J Clin Chem Clin Biochem; 1981 May; 19(5):287-90. PubMed ID: 6167657
[TBL] [Abstract][Full Text] [Related]
4. [Fibrinolytic inhibitory proteins of the hemostaseologic system in normal, inflammatory and bloody cerebrospinal fluid].
Hindersin P; Heidrich R
Psychiatr Neurol Med Psychol (Leipz); 1980 Jun; 32(6):328-37. PubMed ID: 6157172
[TBL] [Abstract][Full Text] [Related]
5. Proteinase inhibitors in cerebrospinal fluid in multiple sclerosis.
Price P; Cuzner ML
J Neurol Sci; 1979 Jul; 42(2):251-9. PubMed ID: 90128
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of establishing chosen acute phase proteins concentrations in serum and cerebrospinal fluid for differential diagnosis and monitoring of purulent meningitis in adults. II].
Lobos M; Paradowski M; Kuydowicz J; Krakowiak M; Kubasiewicz-Ujma B; Wrodycki W
Przegl Epidemiol; 1994; 48(3):191-6. PubMed ID: 7938621
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
Micksche M; Kokron O
Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
[TBL] [Abstract][Full Text] [Related]
8. [The content of the protein markers of hemato-encephalic barrier permeability in the cerebrospinal fluid in severe craniocerebral trauma].
Kuksinskiĭ VA; Lutsik AA; Churliaev IuA; Lykova OF; Nikiforova NV; Martynenkov VIa; Bykov KV
Zh Vopr Neirokhir Im N N Burdenko; 1998; (2):26-7. PubMed ID: 9720164
[TBL] [Abstract][Full Text] [Related]
9. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
10. Chromogenic assay for equine plasminogen.
Welles EG; Prasse KW; Duncan A
Am J Vet Res; 1990 Jul; 51(7):1080-5. PubMed ID: 1697146
[TBL] [Abstract][Full Text] [Related]
11. Changes in concanavalin A-reactive proteins in neurological disorders.
Saso L; Valentini G; Leone MG; Grippa E; Guglielmi R; Paris L; Cantore G; Silvestrini B
J Clin Lab Anal; 1999; 13(4):158-65. PubMed ID: 10414595
[TBL] [Abstract][Full Text] [Related]
12. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
Chmielewska J; Latallo ZS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative levels of serum amyloid A protein and other proteins in cerebrospinal fluid and serum of patients with meningitis].
Shimetani N; Ichikawa K; Shibuya M; Mashiko T; Matsuyama N; Kanoh Y; Ohtani H
Rinsho Byori; 1998 Sep; 46(9):930-5. PubMed ID: 9800479
[TBL] [Abstract][Full Text] [Related]
14. [alpha 2-Macroglobulin in serum and plasma: reference values with carbobenzoxy-valyl-glycyl-arginine-p-nitroanilide, a chromogenic substrate].
Witt I; Tritschler W
J Clin Chem Clin Biochem; 1983 Jul; 21(7):429-36. PubMed ID: 6194247
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of establishing chosen acute phase proteins concentrations in serum and cerebrospinal fluid for differential diagnosis and monitoring of purulent meningitis in adults. I].
Paradowski M; Lobos M; Kuydowicz J; Krakowiak M; Kubasiewicz-Ujma B; Wrodycki W
Przegl Epidemiol; 1994; 48(3):181-90. PubMed ID: 7938620
[TBL] [Abstract][Full Text] [Related]
16. [Alpha-2 macroglobulin from cerebrospinal fluid in neurosurgical diseases].
Vasil'eva TG; Dobrogorskaia LN; Kraeva LN; Goncharova VP
Vopr Med Khim; 1989; 35(6):48-51. PubMed ID: 2483469
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
Vinazzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
[TBL] [Abstract][Full Text] [Related]
19. Assessment of inhibitors with chromogenic substrates.
Latallo ZS
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():48-9. PubMed ID: 6159376
[No Abstract] [Full Text] [Related]
20. [Proteinase inhibitor activity of blood plasma and cerebrospinal fluid in patients with pituitary adenomas before and after proton therapy].
Zargarova OP; Konnova LA
Vopr Med Khim; 1983; 29(6):96-8. PubMed ID: 6199897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
